<SEC-DOCUMENT>0000950170-25-011781.txt : 20250131
<SEC-HEADER>0000950170-25-011781.hdr.sgml : 20250131
<ACCEPTANCE-DATETIME>20250131162829
ACCESSION NUMBER:		0000950170-25-011781
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250131

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enfusion, Inc.
		CENTRAL INDEX KEY:			0001868912
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93478
		FILM NUMBER:		25578713

	BUSINESS ADDRESS:	
		STREET 1:		125 SOUTH CLARK STREET, SUITE 750
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60603
		BUSINESS PHONE:		(312) 253-9800

	MAIL ADDRESS:	
		STREET 1:		125 SOUTH CLARK STREET, SUITE 750
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60603

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Malherbe Investments LLC
		CENTRAL INDEX KEY:			0001911630
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O ENFUSION, INC.
		STREET 2:		125 SOUTH CLARK STREET, SUITE 750
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60603
		BUSINESS PHONE:		312-253-9800

	MAIL ADDRESS:	
		STREET 1:		C/O ENFUSION, INC.
		STREET 2:		125 SOUTH CLARK STREET, SUITE 750
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60603

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Malherbe INvestments LLC
		DATE OF NAME CHANGE:	20220216
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001104659-22-024316</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001911630</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Class A common stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001868912</issuerCik>
        <issuerName>Enfusion, Inc.</issuerName>
        <issuerCusip>292812104</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">125 South Clark Street, Suite 750</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Chicago</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">IL</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">60603</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Malherbe Investments LLC</reportingPersonName>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>6870386</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>6870386</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>6870386</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.79</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.

Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Stephen Malherbe</reportingPersonName>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>6870386</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>6870386</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>6870386</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.79</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.
Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Enfusion, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>125 South Clark Street, Suite 750, Chicago, Illinois 60603</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by Malherbe Investments LLC and Stephen Malherbe (together, the "Reporting Persons"). Mr. Malherbe is the sole manager of Malherbe Investments LLC and may be deemed the beneficial owner of the shares held by Malherbe Investments LLC.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business office address of the Reporting Persons is 1063 Gallant Court, Wheaton, Illinois 60187.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Malherbe Investments LLC is a Delaware limited liability company and Stephen Malherbe is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See responses to Item 9 on each cover page hereto.</amountBeneficiallyOwned>
        <classPercent>See responses to Item 11 on each cover page hereto.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See responses to Item 5 on each cover page hereto.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See responses to Item 6 on each cover page hereto.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See responses to Item 7 on each cover page hereto.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See responses to Item 8 on each cover page hereto.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Malherbe Investments LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Stephen Malherbe</signature>
        <title>Sole Manager</title>
        <date>01/31/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Stephen Malherbe</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Stephen Malherbe</signature>
        <title>Stephen Malherbe</title>
        <date>01/31/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
